International Forum of Allergy & Rhinology

Papers
(The H4-Index of International Forum of Allergy & Rhinology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
435
312
Response to “Letter to the Editor Regarding Ambient Particulate Matter and Frequency of Outpatient Visits for Chronic Rhinosinusitis in the United States”130
77
62
Nitric oxide–generating microparticles: An in vitro evaluation of anti‐biofilm efficacy and sinonasal epithelial cell cytotoxicity55
Surgical complications in combined rhinoplasty and endoscopic sinus surgery55
Letter to the editor regarding “Long‐term quality‐of‐life impairment in patients with more than 1‐year COVID‐19–related olfactory dysfunction”37
Letter to the editor regarding “Intralesional cidofovir injections for the treatment of multifocal exophytic sinonasal papilloma”: The utility of topical cidofovir34
Reply to: “Air pollution exposure is associated with rhinitis in older US adults via specific immune mechanisms”32
Orbital resection by intranasal technique (ORBIT): A new classification system for reporting endoscopically resectable primary benign orbital tumors31
The association between olfactory subdomains and frailty: A prospective case‒control study investigation31
Levels of nasal nitric oxide and nitric oxide synthase expression in chronic rhinosinusitis with nasal polyposis31
Incidence, risk factors, and prognostic value of nodal involvement in sinonasal cancers28
Altered Nasal Microbiota in Sinonasal Tumors: A Comparative Analysis of Malignant and Benign Sinonasal Tumors26
Immune Receptor Repertoire Analyses Reveal Dynamics of Adaptive Immunity in Acute Invasive Fungal Sinusitis25
Association Between US Wildfires and Health Care Utilization for Acute Rhinosinusitis25
Moderate to Vigorous Physical Activity and Chronic Rhinosinusitis Risk: A Longitudinal Fitbit Study24
Akt activator SC79 stimulates antibacterial nitric oxide generation in human nasal epithelial cells in vitro23
Calprotectin in chronic rhinosinusitis eosinophil extracellular traps23
Gabapentin improves parosmia after COVID‐19 infection23
Comment on “Female‐Specific Risk of TAS2R Variants in Chronic Rhinosinusitis: A Hospital‐Based Cohort Study From the Taiwan Precision Medicine Initiative”22
0.33447504043579